Download presentation
Presentation is loading. Please wait.
Published bySri Kurnia Modified over 5 years ago
1
Fig. 2 CD19 CAR T cells expressing tPSMA maintain function in vitro and in vivo.
CD19 CAR T cells expressing tPSMA maintain function in vitro and in vivo. (A) Mock or CD19-tPSMA CAR T cells were incubated with K562-CD19-NLR target cells at a ratio of 4:1. Target cells were analyzed every 2 hours using an IncuCyte live cell imaging system. (B) A kill index [1/area under the curve (AUC)] was calculated at the indicated effector:target ratio. (C and D) Nalm6-GFP-fLuc tumor cells were injected intravenously into female NOD scid (nonobese diabetic severe combined immunodeficient) gamma (NSG) mice (n = 8 per group) on day 0, and 1 × 106 mock or CAR T cells were injected on day 4. Whole-body bioluminescence imaging (BLI) was performed to determine tumor burden, with data displayed as average radiance for each group (C), and survival events were recorded (D). Il Minn et al. Sci Adv 2019;5:eaaw5096 Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC).
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.